Cholecalciferol for myocardial infarction

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Dec 2016: Trial registered, NCT02996721
  2. 3 Apr 2017: Trial started, NCT02996721

The trials

NCT02996721: A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients

State
Completed
Phase
Phase 4
People
634 taking part
Started
3 Apr 2017
Primary completion
30 Mar 2025
Arms
Treatment
Results
None posted
  1. 19 Dec 2016: Trial registered
  2. 3 Apr 2017: Trial started
  3. 4 Sep 2025: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Also known as Aquadetrim, Arachitol, Bolus vitamin D3, Calciol, Calcirol, CapsuDar D3 100E, D3-Vigantol, Daily Vitamin D3, Davitamon D, Decara, Decristol, Delsterol, Deparal, Devaron, Devikap, Dry Vitamin D3 100CWS/AM, Duphafral D3 1000, Ekostop D3, FeraCol, Granuvit D3, High-D 2X, Lutavit D, Minisun, Oleovit D3, OsteVit D, Plivit D3, Quintox, Riken D3 Oil 100, Riken D3 Oil 20, Rovimix D3 500, Uvedose, Vi-De3, Videkhol, Vigantol, Vigorsan, Vitamin D3, Vitamin D3 S 50t, Vitamin D3, Cholecalciferol, Vitinc Dan-Dee-3.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.